These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2224437)

  • 1. Persistent carcinoma in situ of the testis after chemotherapy for advanced testicular germ cell tumours.
    Bottomley D; Fisher C; Hendry WF; Horwich A
    Br J Urol; 1990 Oct; 66(4):420-4. PubMed ID: 2224437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of the contralateral testis in patients with testicular germ cell cancer.
    Fordham MV; Mason MD; Blackmore C; Hendry WF; Horwich A
    Br J Urol; 1990 Mar; 65(3):290-3. PubMed ID: 2337749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ.
    Oliver RT; Ong J; Berney D; Nargund V; Badenoch D; Shamash J
    APMIS; 2003 Jan; 111(1):86-91; discussion 91-2. PubMed ID: 12752243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bilateral and synchronous testicular teratoma: a case report and literature review].
    Matabuena-Tamez P; Canepa-Fernández P; Valencia-García LC; Gutiérrez-Samperio C; Gallegos-Corona MA
    Cir Cir; 2015; 83(6):527-31. PubMed ID: 26164135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer.
    Rud CN; Daugaard G; Rajpert-De Meyts E; Skakkebæk NE; Petersen JH; Jørgensen N
    J Urol; 2013 Dec; 190(6):2074-80. PubMed ID: 23770148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery following chemotherapy for metastatic testicular teratoma.
    Whillis D; Coleman RE; Lessells AM; Hargreave TB; Cornbleet MA; Howard GC
    Br J Urol; 1991 Sep; 68(3):292-5. PubMed ID: 1913071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients.
    von der Maase H; Rørth M; Walbom-Jørgensen S; Sørensen BL; Christophersen IS; Hald T; Jacobsen GK; Berthelsen JG; Skakkebaek NE
    Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1398-401. PubMed ID: 3026550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
    Amato RJ; Ro JY; Ayala AG; Swanson DA
    Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma in situ of the testis followed by an overt malignant teratoma of the testis within 12 months.
    Mark SD; Gowland SP; Arnold EP; McRae CU; Fitzharris BM
    Aust N Z J Surg; 1994 Dec; 64(12):862-4. PubMed ID: 7980264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Is it indicated?
    Simmonds PD; Mead GM; Lee AH; Theaker JM; Dewbury K; Smart CJ
    Cancer; 1995 Feb; 75(4):1018-24. PubMed ID: 7842403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The synchronous appearance of multiple testicular epidermoid cysts and of a malignant mixed germinal tumor in the contralateral testis].
    Stark L; Potratz D; Schäfer R; von Vietsch H
    Urologe A; 1992 Mar; 31(2):85-7. PubMed ID: 1314002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of contralateral testicular intraepithelial neoplasia in patients with testicular germ-cell tumor.
    Dieckmann KP; Loy V
    World J Urol; 1994; 12(3):131-5. PubMed ID: 7951338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial orchidectomy for malignancy with consideration of carcinoma in situ.
    Hughes PD
    ANZ J Surg; 2006; 76(1-2):92-4. PubMed ID: 16483305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current issues in the management of clinical stage I testicular teratoma.
    Horwich A
    Eur J Cancer; 1993; 29A(7):933-4. PubMed ID: 8499143
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma in situ of the testis: review of biological and clinical features.
    Dieckmann KP; Skakkebaek NE
    Int J Cancer; 1999 Dec; 83(6):815-22. PubMed ID: 10597201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chemotherapy on carcinoma in situ of the testis.
    Christensen TB; Daugaard G; Geertsen PF; von der Maase H
    Ann Oncol; 1998 Jun; 9(6):657-60. PubMed ID: 9681081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor.
    Calaminus G; Schneider DT; Weissbach L; Schönberger S; Okpanyi V; Leuschner I; Poremba C; Göbel U
    Klin Padiatr; 2009; 221(3):136-40. PubMed ID: 19437360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of testicular cancer: 10-year experience.
    Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
    Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is organ saving surgery of testicular tumor justified?].
    Weissbach L
    Urologe A; 1993 Jan; 32(1):49-52. PubMed ID: 8383368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.